EY German Biotech Report 2025 Roadshow!
Which pathways will lead German biotechnology to success? Join Us for the EY German Biotech Report 2025 Roadshow!
This year’s German Biotechnology Report 2025, a collaborative effort between EY and BIO Deutschland e.V. is dedicated to this central question. In a changing global world order, it is of crucial importance to utilise existing strengths to exploit existing opportunities.
Together with the Heidelberg Technology Park we therefore invite you to a presentation of facts, figures and data.
Discover the latest insights and trends shaping the future of biotechnology in Germany. The 2025 edition of the EY German Biotech Report dives deep into the sector’s growth, challenges, and opportunities, providing a comprehensive analysis of early-stage investments, international benchmarks, and strategic recommendations. This year’s report focuses on examining the strength and potential of German biotech from various angles, also covering aspects such as the role of strategic partnerships, strategies for resilience and innovation during times of geopolitical tensions, and how biotechnology is revolutionizing the food industry. We will also take a look at Switzerland and get insights from the Swiss Biotech Report.
Agenda:
4:00 pm Welcome Dr. Nicole Hecht bioRN Network e.V., Klaus Ort, EY Parthenon Deutschland and Dr. André Domin, Technologiepark Heidelberg
Presentation facts and figures bioRN
4:15 pm Presentation results EY German Biotechnology Report, Julia Schüler BioAspekte
4:35 pm A look at Switzerland: Results from the Swiss Biotech Report, Frederik Schmachtenberg & Gabriela Güntherodt,
EY Parthenon
4:45 pm Dr. Christoph Antz, CEO Veraxa: “on the way to the US stock exchange”
4:50 pm The strategic role of German biotech in the European context
Open Discussion with speakers + bioRN member companies
5:15 pm Wrap Up and Closing
Get Together
You will have plenty of opportunity for further dialogue and networking at the following get-together.
register now
